Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma

European Surgical Research

Volumn 38, Issue 3, 2006, Pages 333-339

  Opitz, Isabelle ^a   Krueger, Thorsten ^a   Pan, Youmin ^a   Altermatt, Hans Jörg ^b   Wagnières, Georges ^c   Ris, Hans Beat ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Unilabs Mittelland   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

Animal model; Experimental surgery; In situ light dosimetry; Mesothelioma; mTHPC; Photodynamic therapy; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT; TEMOPORFIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER TRANSPLANTATION; CONTROLLED STUDY; DEVICE; DOSE RESPONSE; DOSIMETRY; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; EVALUATION; HISTOLOGY; ILLUMINATION; LASER; MALE; MALIGNANT PLEURAL MESOTHELIOMA; MYOCARDITIS; NONHUMAN; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; RAT; SHOCK LUNG; TUMOR MODEL; TUMOR NECROSIS;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; MESOPORPHYRINS; MESOTHELIOMA; MICE; NECROSIS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PLEURAL NEOPLASMS; PORPHYRINS; RATS; RATS, INBRED F344; SURVIVAL RATE;

EID: 33746604733     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094028     Document Type: Article

References (25)

1. Peto J, Decarli A, La Vecchia C, Levi F, Negri E: The European mesothelioma epidemic. Br J Cancer 1999;79:666-672.
2. Baldini EH, Recht A, Strauss GM, DeCamp JMM, Swanson SJ: Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 1997;63:334-338.
3. Rusch V, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, Bains M, Downey R, Ginsberg R: A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122:788-795.
4. Ris HB, Altermatt H, Nachbur B, Stewart C, Wang Q, Lim C, Bonnett R, Althaus U: Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg Med 1996;18:39-45.
5. Pass H, Temeck B, Krandam K, Thomas G, Russo A, Smith P, Friauf W, Steinberg S: Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 1997;4:628-633.
6. Moskal TL, Dougherty TJ, Urschel JD, Antkowiak JG, Regal AM, Driscoll DL, Takita H: Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann Thorac Surg 1998;66:1128.
7. Schouwink H, Rutgers ET, van der Sijp J, Oppelaar H, van Zandwijk N, van Veen R, Burgers S, Stewart FA, Zoetmulder F, Baas P: Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma. Chest 2001;20:1167-1174.
8. Gibson S, Foster T, Feins R, Raubertas R, Fallon M, Hilf R: Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Br J Cancer 1994;69:473-481.
9. Ris HB, Altermatt H, Stewart C, Schaffner T, Wang Q, Lim C, Bonnett R, Althaus U: Photodynamic therapy with meta-tetrahydroxyphenylchlorin in vivo: Optimization of the therapeutic index. Int J Cancer 1993;55:245-249.
10. Ris HB, Krueger T, Giger A, Lim C, Stewart J, Althaus U, Altermatt H: Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts. Br J Cancer 1999;79:1061-1066.
11. Tochner Z, Pass H, Smith P, DeLAney T, Sprague M, DeLuca A, Harrington F, Thomas G, Terrill R, Bacher J: Intrathoracic photodynamic therapy: a canine normal tissue tolerance study and early clinical experience. Lasers Surg Med 1994;14:118-123.
12. Pelton J, Kowalyshyn M, Keller S: Intrathoracic organ injury associated with photodynamic therapy. J Thorac Cardiovasc Surg 1992;103:1218-1223.
13. Krueger T, Altermatt H, Mettler D, Scholl B, Magnusson L, Ris HB: Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC. Lasers Surg Med 2003;32:61-68.
14. Krueger T, Pan Y, Tran N, Altermatt H, Opitz I, Ris HB: Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma-bearing rats. Lasers Surg Med 2005;37:271-277.
15. Kucharczuk JC, Elshami AA, Zhang HB, Smythe WR, Hwang HC, Tomlinson JS, Amin KM, Litzky LA, Albelda SM, Kaiser LR: Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transfer. Ann Thorac Surg 1995;60:593-597.
16. Bonnett R, White R, Winfield U, Berenbaum M: Hydroporphyrins of the mesotetra(hydr oxyphenyl)porphyrin series as tumour photosensitizer. Biochem J 1989;261:277-280.
17. Soubrane G, Kuhn D, Coscas G: Indications for photodynamic therapy in age-related macular degeneration. J Fr Ophtalmol 2004;27:79-80.
18. Barbazetto IA, Lee TC, Rollins IS, Chang S, Abramson DH: Treatment of choroidal melanoma using photodynamic therapy. Am J Ophthalmol 2003;135:898.
19. Barbazetto I, Smith R: Vasoproliferative tumor of the retina treated with PDT. Retina 2003;23:565-567.
20. Wagnieres G, Hadjur C, Grosjean P, Braichotte D, Savary J, Monnier P, van den Bergh H: Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin. Photochem Photobiol 1998;68:382-387.
21. Star W: Light dosimetry in vivo. Phys Med Biol 1997;42:763-787.
22. Marijnissen J, Star W: Calibration of isotropic light dosimetry probes based on scattering bulbs in clear media. Phys Med Biol 1996;41:1191-1208.
23. Dwyer P, White W, Fabian R, Anderson R: Optical integrating balloon device for photodynamic therapy. Lasers Surg Med 2000;26:58-66.
24. Bessler N, Committee VSW: Verteporfin therapy in age-related macular degeneration: an open-label multicenter photodynamic therapy study of 4,435 patients. Retina 2004;24:512-520.
25. Dougherty T: An update on photodynamic therapy applications. J Clin Laser Med Surg 2002;20:3-7.